94 related articles for article (PubMed ID: 2365056)
1. CD4 molecules are restricted to the basolateral membrane domain of in vitro differentiated human colon cancer cells (HT29-D4).
Rabenandrasana C; Baghdiguian S; Marvaldi J; Fantini J
FEBS Lett; 1990 Jun; 265(1-2):75-9. PubMed ID: 2365056
[TBL] [Abstract][Full Text] [Related]
2. Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells.
Fantini J; Rognoni JB; Culouscou JM; Pommier G; Marvaldi J; Tirard A
J Cell Physiol; 1989 Oct; 141(1):126-34. PubMed ID: 2674159
[TBL] [Abstract][Full Text] [Related]
3. Surface distribution of the EGF receptor during differentiation of the human colon carcinoma cell line HT29-D4.
Lehmann M; Remacle-Bonnet M; Garrouste F; Luis J; Rabenandrasana C; Marvaldi J; Pommier G
J Recept Res; 1994 Jul; 14(5):319-33. PubMed ID: 7815389
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of a clone isolated from the HT29 cell line: polarized distribution of histocompatibility antigens (HLA) and of transferrin receptors.
Godefroy O; Huet C; Blair LA; Sahuquillo-Merino C; Louvard D
Biol Cell; 1988; 63(1):41-55. PubMed ID: 3191295
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells.
Fantini J; Yahi N; Chermann JC
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9297-301. PubMed ID: 1718004
[TBL] [Abstract][Full Text] [Related]
6. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
[TBL] [Abstract][Full Text] [Related]
7. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
Fantini J; Rognoni JB; Verrier B; Lehmann M; Roccabianca M; Mauchamp J; Marvaldi J
Eur J Cell Biol; 1990 Feb; 51(1):110-9. PubMed ID: 2328732
[TBL] [Abstract][Full Text] [Related]
8. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
[TBL] [Abstract][Full Text] [Related]
9. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.
Baghdiguian S; Verrier B; Gerard C; Fantini J
Cancer Lett; 1992 Feb; 62(1):23-33. PubMed ID: 1311629
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of biochemical, electrophysiological and morphological events (including lysosomal disorder) during the course of suramin-induced differentiation of the human colon-cancer cell clone HT29-D4.
Baghdiguian S; Verrier B; Marvaldi J; Fantini J
Int J Cancer; 1991 Oct; 49(4):608-15. PubMed ID: 1917163
[TBL] [Abstract][Full Text] [Related]
11. Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4.
Fantini J; Rognoni JB; Roccabianca M; Pommier G; Marvaldi J
J Biol Chem; 1989 Jun; 264(17):10282-6. PubMed ID: 2656707
[TBL] [Abstract][Full Text] [Related]
12. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. Unique apical sorting of insulin-like growth factor binding protein-6 in differentiated human colon cancer cells.
Remacle-Bonnet M; Garrouste F; el Atiq F; Marvaldi J; Pommier G
J Clin Invest; 1995 Jul; 96(1):192-200. PubMed ID: 7542277
[TBL] [Abstract][Full Text] [Related]
13. Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium.
Fantini J; Verrier B; Robert C; Pic P; Pichon J; Mauchamp J; Marvaldi J
Exp Cell Res; 1990 Jul; 189(1):109-17. PubMed ID: 2161345
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
Garrouste FL; Remacle-Bonnet MM; Lehmann MM; Marvaldi JL; Pommier GJ
Endocrinology; 1997 May; 138(5):2021-32. PubMed ID: 9112401
[TBL] [Abstract][Full Text] [Related]
15. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
[TBL] [Abstract][Full Text] [Related]
16. In vitro differentiated HT 29-D4 clonal cell line generates leakproof and electrically active monolayers when cultured in porous-bottom culture dishes.
Fantini J; Verrier B; Marvaldi J; Mauchamp J
Biol Cell; 1989; 65(2):163-9. PubMed ID: 2736330
[TBL] [Abstract][Full Text] [Related]
17. Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cells.
Baghdiguian S; Verrier B; Marvaldi J; Fantini J
J Cell Physiol; 1992 Jan; 150(1):168-74. PubMed ID: 1730780
[TBL] [Abstract][Full Text] [Related]
18. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells.
Yahi N; Baghdiguian S; Moreau H; Fantini J
J Virol; 1992 Aug; 66(8):4848-54. PubMed ID: 1378511
[TBL] [Abstract][Full Text] [Related]
19. Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation.
Huet C; Sahuquillo-Merino C; Coudrier E; Louvard D
J Cell Biol; 1987 Jul; 105(1):345-57. PubMed ID: 3611191
[TBL] [Abstract][Full Text] [Related]
20. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.
Fantini J; Cook DG; Nathanson N; Spitalnik SL; Gonzalez-Scarano F
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2700-4. PubMed ID: 8464878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
